poisar

Stock

Alamar Biosciences, Inc. ALMR

$33.16+0.73%

Overview

ALMR market data

Price History

ALMR price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.45
Diluted earnings per share over the trailing twelve months.
Beta
-0.12
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-40.2%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$18.85 – $38.54
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $1.9B.

Company News

10 captured
Top 3 Health Care Stocks That May Implode In AugustBenzinga · Aug 12, 2026, 12:58 PM
Stifel Maintains Buy on Alamar Biosciences, Raises Price Target to $32Benzinga · Aug 11, 2026, 5:41 PM
Alamar Biosciences Stock Soars, CEO Says Company Is Well-Positioned to Sustain Upcoming MomentumBenzinga · Aug 11, 2026, 5:25 PM
12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga · Aug 11, 2026, 5:06 PM
Alamar Biosciences shares are trading higher after the company reported better-than-expected Q2 financial results. Also, JP Morgan maintained its Overweight rating on the stock and raised its price target from $32 to $35.Benzinga · Aug 11, 2026, 2:23 PM
JP Morgan Maintains Overweight on Alamar Biosciences, Raises Price Target to $35Benzinga · Aug 11, 2026, 2:09 PM
Quantum, Kopin, Alamar Biosciences And Other Big Stocks Moving Higher On TuesdayBenzinga · Aug 11, 2026, 2:08 PM
Alamar Biosciences Sees FY2026 Sales $116.000M-$120.000M vs $113.259M EstBenzinga · Aug 10, 2026, 8:42 PM
Alamar Biosciences Q2 EPS $(0.22) Beats $(0.33) Estimate, Sales $29.427M Beat $25.940M EstimateBenzinga · Aug 10, 2026, 8:13 PM
8-K filing — Alamar Biosciences, Inc. (ALMR)SEC EDGAR · Aug 10, 2026, 8:10 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock